Showing 28,961 - 28,980 results of 224,509 for search '(( a ((((larger decrease) OR (a decrease))) OR (linear decrease)) ) OR ( a largest decrease ))', query time: 1.98s Refine Results
  1. 28961
  2. 28962
  3. 28963
  4. 28964

    Decreased plaque size in ORP8 KO BM recipients and increased plaque macrophage content after 9 weeks WTD feeding. by Erik van Kampen (649704)

    Published 2014
    “…After 9 weeks of WTD feeding following BMT, a decrease in plaque size could be measured. No difference was observed after 6 weeks of dietary challenge. …”
  5. 28965
  6. 28966
  7. 28967
  8. 28968
  9. 28969
  10. 28970
  11. 28971
  12. 28972
  13. 28973
  14. 28974
  15. 28975
  16. 28976

    The Ras Antagonist, Farnesylthiosalicylic Acid (FTS), Decreases Fibrosis and Improves Muscle Strength in <em>dy</em> Mouse Model of Muscular Dystrophy by Yoram Nevo (226898)

    Published 2011
    “…FTS treatment significantly decreased RAS expression and activity. In addition, phosphorylation of ERK, a Ras downstream protein, was significantly decreased following FTS treatment in the <em>dy<sup>2J</sup></em>/<em>dy<sup>2J</sup></em> mice. …”
  17. 28977
  18. 28978

    Increased mTOR and decreased AMPK activation in <i>Fnip1</i> null kidney tissue and renal tubular epithelial cells. by Ryan Centini (5390768)

    Published 2018
    “…<p>(A) Representative immunoblots showing decreased AMPK activation (pAMPKThr172) and increased mTORC1 activation (p-S6R, p-4EBP1) in total renal tissue from <i>Fnip1</i><sup><i>-/-</i></sup> and WT mice. …”
  19. 28979
  20. 28980

    Human microRNA-299-3p decreases invasive behavior of cancer cells by downregulation of Oct4 expression and causes apoptosis by Axel R. Göhring (3937004)

    Published 2017
    “…</p><p>Methods and results</p><p>High throughput luciferase activity assay revealed the microRNA-299-3p to be the most effective in reducing gene expression of Oct4, which was confirmed by Western blot analysis and Oct4 promoter activity in a target luciferase assay. Furthermore, it could be demonstrated that downregulation of Oct4 by microRNAs-299-3p in breast cancer and fibrosarcoma cells lead to a decreased invasiveness in a microfluidic chip assay. …”